|
US439912A
(en)
|
|
1890-11-04 |
|
Shutter worker |
|
US3654090A
(en)
|
1968-09-24 |
1972-04-04 |
Organon |
Method for the determination of antigens and antibodies
|
|
USRE31006E
(en)
|
1968-09-24 |
1982-08-03 |
Akzona Incorporated |
Process for the demonstration and determination of reaction components having specific binding affinity for each other
|
|
NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
|
CU22545A1
(es)
|
1994-11-18 |
1999-03-31 |
Centro Inmunologia Molecular |
Obtención de un anticuerpo quimérico y humanizado contra el receptor del factor de crecimiento epidérmico para uso diagnóstico y terapéutico
|
|
US4016043A
(en)
|
1975-09-04 |
1977-04-05 |
Akzona Incorporated |
Enzymatic immunological method for the determination of antigens and antibodies
|
|
US4162940A
(en)
|
1977-03-31 |
1979-07-31 |
Takeda Chemical Industries, Ltd. |
Method for producing Antibiotic C-15003 by culturing nocardia
|
|
US4151042A
(en)
|
1977-03-31 |
1979-04-24 |
Takeda Chemical Industries, Ltd. |
Method for producing maytansinol and its derivatives
|
|
US4169888A
(en)
|
1977-10-17 |
1979-10-02 |
The Upjohn Company |
Composition of matter and process
|
|
US4137230A
(en)
|
1977-11-14 |
1979-01-30 |
Takeda Chemical Industries, Ltd. |
Method for the production of maytansinoids
|
|
US4265814A
(en)
|
1978-03-24 |
1981-05-05 |
Takeda Chemical Industries |
Matansinol 3-n-hexadecanoate
|
|
US4307016A
(en)
|
1978-03-24 |
1981-12-22 |
Takeda Chemical Industries, Ltd. |
Demethyl maytansinoids
|
|
JPS5562090A
(en)
|
1978-10-27 |
1980-05-10 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
JPS5566585A
(en)
|
1978-11-14 |
1980-05-20 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
JPS55164687A
(en)
|
1979-06-11 |
1980-12-22 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
US4256746A
(en)
|
1978-11-14 |
1981-03-17 |
Takeda Chemical Industries |
Dechloromaytansinoids, their pharmaceutical compositions and method of use
|
|
US4263294A
(en)
|
1978-11-20 |
1981-04-21 |
Takeda Chemical Industries, Ltd. |
Maytansinoids, pharmaceutical compositions thereof and method of use thereof
|
|
JPS55102583A
(en)
|
1979-01-31 |
1980-08-05 |
Takeda Chem Ind Ltd |
20-acyloxy-20-demethylmaytansinoid compound
|
|
JPS55162791A
(en)
|
1979-06-05 |
1980-12-18 |
Takeda Chem Ind Ltd |
Antibiotic c-15003pnd and its preparation
|
|
JPS55164685A
(en)
|
1979-06-08 |
1980-12-22 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
JPS55164686A
(en)
|
1979-06-11 |
1980-12-22 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
US4309428A
(en)
|
1979-07-30 |
1982-01-05 |
Takeda Chemical Industries, Ltd. |
Maytansinoids
|
|
JPS5622790A
(en)
|
1979-07-31 |
1981-03-03 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
JPS5645483A
(en)
|
1979-09-19 |
1981-04-25 |
Takeda Chem Ind Ltd |
C-15003phm and its preparation
|
|
EP0028683A1
(en)
|
1979-09-21 |
1981-05-20 |
Takeda Chemical Industries, Ltd. |
Antibiotic C-15003 PHO and production thereof
|
|
JPS5645485A
(en)
|
1979-09-21 |
1981-04-25 |
Takeda Chem Ind Ltd |
Production of c-15003pnd
|
|
US4491632A
(en)
|
1979-10-22 |
1985-01-01 |
The Massachusetts General Hospital |
Process for producing antibodies to hepatitis virus and cell lines therefor
|
|
US4444887A
(en)
|
1979-12-10 |
1984-04-24 |
Sloan-Kettering Institute |
Process for making human antibody producing B-lymphocytes
|
|
US4342566A
(en)
|
1980-02-22 |
1982-08-03 |
Scripps Clinic & Research Foundation |
Solid phase anti-C3 assay for detection of immune complexes
|
|
EP0043718B1
(en)
|
1980-07-07 |
1984-11-28 |
National Research Development Corporation |
Improvements in or relating to cell lines
|
|
US4341761A
(en)
|
1980-07-25 |
1982-07-27 |
E. I. Du Pont De Nemours And Company |
Antibodies to immunogenic peptides and their use to purify human fibroblast interferon
|
|
WO1982001188A1
(en)
|
1980-10-08 |
1982-04-15 |
Takeda Chemical Industries Ltd |
4,5-deoxymaytansinoide compounds and process for preparing same
|
|
US4413132A
(en)
|
1980-11-18 |
1983-11-01 |
The Upjohn Company |
Antibiotic CC-1065 indoline intermediates
|
|
US4313946A
(en)
|
1981-01-27 |
1982-02-02 |
The United States Of America As Represented By The Secretary Of Agriculture |
Chemotherapeutically active maytansinoids from Trewia nudiflora
|
|
US4466917A
(en)
|
1981-02-12 |
1984-08-21 |
New York University |
Malaria vaccine
|
|
US4493890A
(en)
|
1981-03-23 |
1985-01-15 |
Miles Laboratories, Inc. |
Activated apoglucose oxidase and its use in specific binding assays
|
|
US4451570A
(en)
|
1981-03-26 |
1984-05-29 |
The Regents Of The University Of California |
Immunoglobulin-secreting human hybridomas from a cultured human lymphoblastoid cell line
|
|
US4399121A
(en)
|
1981-11-04 |
1983-08-16 |
Miles Laboratories, Inc. |
Iodothyronine immunogens and antibodies
|
|
US4427783A
(en)
|
1981-12-14 |
1984-01-24 |
Hoffmann-La Roche Inc. |
Immunoassay of thymosin α1
|
|
US4867973A
(en)
|
1984-08-31 |
1989-09-19 |
Cytogen Corporation |
Antibody-therapeutic agent conjugates
|
|
US4671958A
(en)
|
1982-03-09 |
1987-06-09 |
Cytogen Corporation |
Antibody conjugates for the delivery of compounds to target sites
|
|
FR2523445A1
(fr)
|
1982-03-17 |
1983-09-23 |
Sanofi Sa |
Nouveaux conjugues associant, par liaison covalente, une enzyme et un anticorps, et associations medicamenteuses utilisant lesdits conjugues
|
|
US4418064A
(en)
|
1982-09-29 |
1983-11-29 |
The United States Of America As Represented By The Secretary Of Agriculture |
Chemotherapeutically active maytansinoids: treflorine, trenudine, and N-methyltrenudone
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4493795A
(en)
|
1983-10-17 |
1985-01-15 |
Syntex (U.S.A.) Inc. |
Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
|
|
EP0491675A1
(en)
|
1984-01-30 |
1992-06-24 |
Imperial Cancer Research Technology Limited |
Improvements relating to growth factors
|
|
US4943533A
(en)
*
|
1984-03-01 |
1990-07-24 |
The Regents Of The University Of California |
Hybrid cell lines that produce monoclonal antibodies to epidermal growth factor receptor
|
|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
|
US5851526A
(en)
|
1985-04-19 |
1998-12-22 |
Ludwig Institute For Cancer Research |
Methods of treating colon cancer utilizing tumor-specific antibodies
|
|
US5776093A
(en)
|
1985-07-05 |
1998-07-07 |
Immunomedics, Inc. |
Method for imaging and treating organs and tissues
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4997913A
(en)
|
1986-06-30 |
1991-03-05 |
Oncogen |
pH-sensitive immunoconjugates and methods for their use in tumor therapy
|
|
IN165717B
(enExample)
|
1986-08-07 |
1989-12-23 |
Battelle Memorial Institute |
|
|
US5034223A
(en)
|
1986-10-09 |
1991-07-23 |
Neorx Corporation |
Methods for improved targeting of antibody, antibody fragments, hormones and other targeting agents, and conjugates thereof
|
|
USRE38008E1
(en)
|
1986-10-09 |
2003-02-25 |
Neorx Corporation |
Methods for improved targeting of antibody, antibody fragments, hormones and other targeting agents, and conjugates thereof
|
|
US5071773A
(en)
|
1986-10-24 |
1991-12-10 |
The Salk Institute For Biological Studies |
Hormone receptor-related bioassays
|
|
US5047324A
(en)
|
1986-12-09 |
1991-09-10 |
Miles Inc. |
Substantially pure enzyme-antibody conjugate preparations
|
|
US5332837A
(en)
|
1986-12-19 |
1994-07-26 |
The Upjohn Company |
CC-1065 analogs
|
|
US4952394A
(en)
|
1987-11-23 |
1990-08-28 |
Bristol-Myers Company |
Drug-monoclonal antibody conjugates
|
|
US4981784A
(en)
|
1987-12-02 |
1991-01-01 |
The Salk Institute For Biological Studies |
Retinoic acid receptor method
|
|
US5563250A
(en)
|
1987-12-02 |
1996-10-08 |
Neorx Corporation |
Cleavable conjugates for the delivery and release of agents in native form
|
|
JP3040121B2
(ja)
|
1988-01-12 |
2000-05-08 |
ジェネンテク，インコーポレイテッド |
増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
|
|
US4937183A
(en)
|
1988-02-03 |
1990-06-26 |
Cytogen Corporation |
Method for the preparation of antibody-fragment conjugates
|
|
IL106992A
(en)
|
1988-02-11 |
1994-06-24 |
Bristol Myers Squibb Co |
Acylhydrazone derivatives of anthracycline and methods for their preparation
|
|
EP0329184A3
(en)
|
1988-02-19 |
1990-05-23 |
Neorx Corporation |
Antimers and antimeric conjugation
|
|
US6010902A
(en)
|
1988-04-04 |
2000-01-04 |
Bristol-Meyers Squibb Company |
Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity
|
|
US5028697A
(en)
|
1988-08-08 |
1991-07-02 |
Eli Lilly And Company |
Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers
|
|
US5541339A
(en)
|
1988-09-12 |
1996-07-30 |
The Upjohn Company |
CC-1065 analogs having two CPI subunits
|
|
AU4128089A
(en)
*
|
1988-09-15 |
1990-03-22 |
Rorer International (Overseas) Inc. |
Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same
|
|
US5171563A
(en)
|
1988-09-30 |
1992-12-15 |
Neorx Corporation |
Cleavable linkers for the reduction of non-target organ retention of immunoconjugates
|
|
EP0440740B1
(en)
|
1988-10-12 |
1993-09-22 |
Centocor, Inc. |
Radiotherapeutic immunoconjugates labeled with iodine-125
|
|
US5217713A
(en)
|
1988-12-27 |
1993-06-08 |
Takeda Chemical Industries, Ltd. |
Cytotoxic bispecific monoclonal antibody, its production and use
|
|
CA2006408A1
(en)
|
1988-12-27 |
1990-06-27 |
Susumu Iwasa |
Bispecific monoclonal antibody, its production and use
|
|
US5013547A
(en)
|
1989-02-07 |
1991-05-07 |
Erbamont, Inc. |
Anticancer drug - antibody conjugates and method for preparing same
|
|
US5116964A
(en)
|
1989-02-23 |
1992-05-26 |
Genentech, Inc. |
Hybrid immunoglobulins
|
|
US5980896A
(en)
|
1989-06-30 |
1999-11-09 |
Bristol-Myers Squibb Company |
Antibodies reactive with human carcinomas
|
|
US6020145A
(en)
|
1989-06-30 |
2000-02-01 |
Bristol-Myers Squibb Company |
Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
|
|
US5332567A
(en)
|
1989-08-24 |
1994-07-26 |
Immunomedics |
Detection and treatment of infections with immunoconjugates
|
|
WO1991003489A1
(en)
|
1989-09-08 |
1991-03-21 |
The Johns Hopkins University |
Structural alterations of the egf receptor gene in human gliomas
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5459061A
(en)
*
|
1990-01-26 |
1995-10-17 |
W. Alton Jones Cell Science Center, Inc. |
Hybridomas producing monoclonal antibodies which specifically bind to continuous epitope on the human EGF receptor and compete with EGF for binding to the EGF receptor
|
|
JPH05504481A
(ja)
|
1990-02-20 |
1993-07-15 |
クールター コーポレイション |
改良された抗体―酵素直接接合体及びその製造方法
|
|
AU7774391A
(en)
|
1990-04-20 |
1991-11-11 |
Ludwig Institute For Cancer Research |
Aberrant, epidermal growth factor receptor dna, rna and protein forms and method
|
|
AU648313B2
(en)
|
1990-04-25 |
1994-04-21 |
Pharmacia & Upjohn Company |
Novel CC-1065 analogs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
ES2246502T3
(es)
|
1990-08-29 |
2006-02-16 |
Genpharm International, Inc. |
Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
|
|
US6248332B1
(en)
|
1990-10-05 |
2001-06-19 |
Medarex, Inc. |
Targeted immunostimulation with bispecific reagents
|
|
FI101678B1
(fi)
|
1990-12-31 |
1998-08-14 |
Akzo Nv |
Happolabiileja kytkentämolekyylejä
|
|
ES2204890T3
(es)
|
1991-03-06 |
2004-05-01 |
Merck Patent Gmbh |
Anticuerpos monoclonales humanizados.
|
|
KR100249937B1
(ko)
*
|
1991-04-25 |
2000-04-01 |
나가야마 오사무 |
인간 인터루킨-6 수용체에 대한 재구성 인간 항체
|
|
EP0519596B1
(en)
|
1991-05-17 |
2005-02-23 |
Merck & Co. Inc. |
A method for reducing the immunogenicity of antibody variable domains
|
|
US6797492B2
(en)
*
|
1991-05-17 |
2004-09-28 |
Merck & Co., Inc. |
Method for reducing the immunogenicity of antibody variable domains
|
|
DK0617706T3
(da)
|
1991-11-25 |
2001-11-12 |
Enzon Inc |
Multivalente antigenbindende proteiner
|
|
DK1024191T3
(da)
|
1991-12-02 |
2008-12-08 |
Medical Res Council |
Fremstilling af autoantistoffer fremvist på fag-overflader ud fra antistofsegmentbiblioteker
|
|
US5869619A
(en)
|
1991-12-13 |
1999-02-09 |
Xoma Corporation |
Modified antibody variable domains
|
|
GB9300059D0
(en)
*
|
1992-01-20 |
1993-03-03 |
Zeneca Ltd |
Quinazoline derivatives
|
|
US5622929A
(en)
|
1992-01-23 |
1997-04-22 |
Bristol-Myers Squibb Company |
Thioether conjugates
|
|
US5714350A
(en)
*
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
|
CA2076465C
(en)
|
1992-03-25 |
2002-11-26 |
Ravi V. J. Chari |
Cell binding agent conjugates of analogues and derivatives of cc-1065
|
|
ES2144440T3
(es)
|
1992-08-18 |
2000-06-16 |
Centro Inmunologia Molecular |
Anticuerpos monoclonales que reconocen el receptor del factor de crecimiento epidermico, celulas y metodos para su produccion y compuestos que los contienen.
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
US5635483A
(en)
|
1992-12-03 |
1997-06-03 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Tumor inhibiting tetrapeptide bearing modified phenethyl amides
|
|
GB9225453D0
(en)
|
1992-12-04 |
1993-01-27 |
Medical Res Council |
Binding proteins
|
|
CA2150262C
(en)
|
1992-12-04 |
2008-07-08 |
Kaspar-Philipp Holliger |
Multivalent and multispecific binding proteins, their manufacture and use
|
|
US5780588A
(en)
|
1993-01-26 |
1998-07-14 |
Arizona Board Of Regents |
Elucidation and synthesis of selected pentapeptides
|
|
US5674977A
(en)
|
1993-02-05 |
1997-10-07 |
The Ontario Cancer Institute |
Branched synthetic peptide conjugate
|
|
US5556623A
(en)
|
1993-03-30 |
1996-09-17 |
Eli Lilly And Company |
Antibody-drug conjugates
|
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
|
US5443953A
(en)
|
1993-12-08 |
1995-08-22 |
Immunomedics, Inc. |
Preparation and use of immunoconjugates
|
|
GB9401182D0
(en)
|
1994-01-21 |
1994-03-16 |
Inst Of Cancer The Research |
Antibodies to EGF receptor and their antitumour effect
|
|
CA2183268C
(en)
|
1994-03-07 |
2001-05-15 |
Edward D. Ball |
Bispecific molecules having clinical utilities
|
|
UA41929C2
(uk)
|
1994-03-17 |
2001-10-15 |
Мерк Патент Гмбх |
Анти-ефрр одноланцюжковий fv,молекула днк,яка його кодує, анти-ефрр антитіло,спосіб одержання анти-ефрр одноланцюжкового fv,спосіб одержання повного анти-ефрр антитіла та фармацевтична композиція (варіанти)
|
|
US5612474A
(en)
|
1994-06-30 |
1997-03-18 |
Eli Lilly And Company |
Acid labile immunoconjugate intermediates
|
|
CU22615A1
(es)
|
1994-06-30 |
2000-02-10 |
Centro Inmunologia Molecular |
Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos
|
|
US5911995A
(en)
|
1994-08-19 |
1999-06-15 |
Regents Of The University Of Minnesota |
EGF-genistein conjugates for the treatment of cancer
|
|
JP4620808B2
(ja)
|
1994-11-28 |
2011-01-26 |
トーマス・ジェファーソン・ユニバーシティ |
突然変異上皮成長因子受容体を標的とする試薬および方法
|
|
JP3607407B2
(ja)
|
1995-04-26 |
2005-01-05 |
株式会社日立製作所 |
半導体記憶装置
|
|
WO1996040662A2
(en)
|
1995-06-07 |
1996-12-19 |
Cellpro, Incorporated |
Aminooxy-containing linker compounds and their application in conjugates
|
|
US6410690B1
(en)
|
1995-06-07 |
2002-06-25 |
Medarex, Inc. |
Therapeutic compounds comprised of anti-Fc receptor antibodies
|
|
US7060808B1
(en)
|
1995-06-07 |
2006-06-13 |
Imclone Systems Incorporated |
Humanized anti-EGF receptor monoclonal antibody
|
|
CA2222231A1
(en)
|
1995-06-07 |
1996-12-19 |
Imclone Systems Incorporated |
Antibody and antibody fragments for inhibiting the growth of tumors
|
|
WO1997012862A1
(en)
|
1995-10-03 |
1997-04-10 |
The Scripps Research Institute |
Cbi analogs of cc-1065 and the duocarmycins
|
|
US6699715B1
(en)
|
1995-11-30 |
2004-03-02 |
Bristol-Myers Squibb Co. |
Modified sFv molecules which mediate adhesion between cells and uses thereof
|
|
WO1997023243A1
(en)
|
1995-12-22 |
1997-07-03 |
Bristol-Myers Squibb Company |
Branched hydrazone linkers
|
|
US5760041A
(en)
|
1996-02-05 |
1998-06-02 |
American Cyanamid Company |
4-aminoquinazoline EGFR Inhibitors
|
|
US5708156A
(en)
*
|
1996-05-31 |
1998-01-13 |
Ilekis; John V. |
Epidermal growth factor receptor-like gene product and its uses
|
|
AU3217897A
(en)
|
1996-05-31 |
1998-01-05 |
Scripps Research Institute, The |
Analogs of cc-1065 and the duocarmycins
|
|
US6759509B1
(en)
|
1996-11-05 |
2004-07-06 |
Bristol-Myers Squibb Company |
Branched peptide linkers
|
|
US5942602A
(en)
*
|
1997-02-13 |
1999-08-24 |
Schering Aktiengessellschaft |
Growth factor receptor antibodies
|
|
US6306393B1
(en)
|
1997-03-24 |
2001-10-23 |
Immunomedics, Inc. |
Immunotherapy of B-cell malignancies using anti-CD22 antibodies
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
US20020173629A1
(en)
|
1997-05-05 |
2002-11-21 |
Aya Jakobovits |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
WO1998052925A1
(en)
|
1997-05-22 |
1998-11-26 |
The Scripps Research Institute |
Analogs of duocarmycin and cc-1065
|
|
WO1999014220A1
(en)
|
1997-09-12 |
1999-03-25 |
Lumigen, Inc. |
Novel compounds for generating chemiluminescence with a peroxidase
|
|
AU756721B2
(en)
|
1997-10-14 |
2003-01-23 |
Scripps Research Institute, The |
iso-CBI and iso-CI analogs of CC-1065 and the duocarmycins
|
|
US6310209B1
(en)
|
1997-12-08 |
2001-10-30 |
The Scripps Research Institute |
Synthesis of CC-1065/duocarmycin analogs
|
|
US6464686B1
(en)
|
1998-01-21 |
2002-10-15 |
Abbott Laboratories |
Polyurethane feeding tube and associated adaptors
|
|
US7553809B2
(en)
|
1998-02-06 |
2009-06-30 |
Ilexus Pty Limited |
Fc receptor modulators and uses thereof
|
|
CA2316860A1
(en)
|
1998-02-06 |
1999-08-12 |
Ilexus Pty. Limited |
Three-dimensional structures and models of fc receptors and uses thereof
|
|
US6417168B1
(en)
|
1998-03-04 |
2002-07-09 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods of treating tumors
|
|
US20030224001A1
(en)
|
1998-03-19 |
2003-12-04 |
Goldstein Neil I. |
Antibody and antibody fragments for inhibiting the growth of tumors
|
|
CA2327505A1
(en)
|
1998-04-28 |
1999-11-04 |
Smithkline Beecham Corporation |
Monoclonal antibodies with reduced immunogenicity
|
|
ZA200007412B
(en)
|
1998-05-15 |
2002-03-12 |
Imclone Systems Inc |
Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases.
|
|
AUPP380498A0
(en)
|
1998-05-29 |
1998-06-25 |
Biomolecular Research Institute Limited |
Egf receptor agonists and antagonists
|
|
US6962702B2
(en)
|
1998-06-22 |
2005-11-08 |
Immunomedics Inc. |
Production and use of novel peptide-based agents for use with bi-specific antibodies
|
|
US20030215387A1
(en)
|
1998-09-04 |
2003-11-20 |
Peter Harrison |
Bifunctional antibodies and their use in targeting anti-tumour agents
|
|
JP2002524504A
(ja)
|
1998-09-11 |
2002-08-06 |
イレクサス・ピーティーワイ・リミテッド |
Ｆｃ受容体調節剤およびそれの使用
|
|
US7396810B1
(en)
|
2000-08-14 |
2008-07-08 |
Oregon Health Sciences University |
Compositions and methods for treating cancer by modulating HER-2 and EGF receptors
|
|
AU782994C
(en)
|
1999-05-14 |
2006-08-24 |
Imclone Llc |
Treatment of refractory human tumors with epidermal growth factor receptor antagonists
|
|
US6946129B1
(en)
|
1999-06-08 |
2005-09-20 |
Seattle Genetics, Inc. |
Recombinant anti-CD40 antibody and uses thereof
|
|
US6949245B1
(en)
|
1999-06-25 |
2005-09-27 |
Genentech, Inc. |
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
|
|
US7303749B1
(en)
|
1999-10-01 |
2007-12-04 |
Immunogen Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
|
JP4776843B2
(ja)
|
1999-10-01 |
2011-09-21 |
イムノゲン インコーポレーティッド |
免疫複合体及び化学療法剤を用いる癌治療用組成物及び方法
|
|
ES2276708T3
(es)
|
1999-11-24 |
2007-07-01 |
Immunogen, Inc. |
Agentes citotoxicos que comprenden taxanos y su uso terapeutico.
|
|
NZ518764A
(en)
|
1999-12-29 |
2004-02-27 |
Immunogen Inc |
Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use
|
|
NZ520622A
(en)
|
2000-02-25 |
2004-08-27 |
Us Gov Health & Human Serv |
Anti-EGFRvIII scFvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof
|
|
EP1276771A4
(en)
|
2000-03-10 |
2003-06-04 |
Thomas Jefferson Univarsity |
Sensitive detection of wild-type and mutant egfr by specific elisa assays in any biological sample
|
|
US7097840B2
(en)
|
2000-03-16 |
2006-08-29 |
Genentech, Inc. |
Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
|
|
AU4761601A
(en)
|
2000-04-11 |
2001-10-23 |
Genentech Inc |
Multivalent antibodies and uses therefor
|
|
US6596302B2
(en)
|
2000-04-13 |
2003-07-22 |
Abbott Laboratories |
Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof
|
|
DE50104114D1
(de)
|
2000-05-02 |
2004-11-18 |
Tietze Lutz F |
Neue prodrugs von 6-hydroxy-2,3-dihydro-1h-indolen, 5-hydroxy-1,2-dihydro-3h-pyrrolo 3,2-e]indolen und 5-hydroxy-1,2-dihydro-3h-benzo e]indolen sowie von 6-hydroxy-1,2,3,4-tetrahydro-benzo f]chinolin-derivaten für eine selektive krebstherapie
|
|
NZ522444A
(en)
|
2000-05-19 |
2004-09-24 |
Genentech Inc |
Gene detection assay for improving the likelihood of an effective response to an ErbB antagonist cancer therapy
|
|
AUPQ841800A0
(en)
|
2000-06-28 |
2000-07-20 |
Biomolecular Research Institute Limited |
Truncated egf receptor
|
|
US20040220388A1
(en)
|
2000-06-30 |
2004-11-04 |
Nico Mertens |
Novel heterodimeric fusion proteins
|
|
EP1311291A4
(en)
|
2000-08-09 |
2007-07-25 |
Imclone Systems Inc |
TREATMENT OF HYPERPROLIFERATIVE DISEASES USING EPIDERMAL GROWTH FACTOR RECEPTOR ANTAGONISTS
|
|
US6333410B1
(en)
|
2000-08-18 |
2001-12-25 |
Immunogen, Inc. |
Process for the preparation and purification of thiol-containing maytansinoids
|
|
AR030612A1
(es)
|
2000-09-12 |
2003-08-27 |
Smithkline Beecham Corp |
Procedimiento e intermedios
|
|
ES2254492T3
(es)
|
2000-09-19 |
2006-06-16 |
Moses Lee |
Composiciones y procedimientos de uso de analogos aquirales de cc-1065 y de duocarmicinas.
|
|
DE10048417A1
(de)
|
2000-09-29 |
2002-04-11 |
Roche Diagnostics Gmbh |
Verbindungen mit verzweigtem Linker
|
|
JP2004511479A
(ja)
|
2000-10-13 |
2004-04-15 |
アストラゼネカ アクチボラグ |
キナゾリン誘導体
|
|
KR20030074839A
(ko)
|
2001-02-19 |
2003-09-19 |
메르크 파텐트 게엠베하 |
감소된 면역원성을 갖는 개질 항-ｅｇｆｒ 항체
|
|
US20080008704A1
(en)
*
|
2001-03-16 |
2008-01-10 |
Mark Rubin |
Methods of treating colorectal cancer with anti-epidermal growth factor antibodies
|
|
US20020156274A1
(en)
|
2001-03-16 |
2002-10-24 |
Terfloth Gerald J. |
Process for preparing maytansinol
|
|
EP1243276A1
(en)
|
2001-03-23 |
2002-09-25 |
Franciscus Marinus Hendrikus De Groot |
Elongated and multiple spacers containing activatible prodrugs
|
|
US20030083263A1
(en)
|
2001-04-30 |
2003-05-01 |
Svetlana Doronina |
Pentapeptide compounds and uses related thereto
|
|
US6884869B2
(en)
|
2001-04-30 |
2005-04-26 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
US7256257B2
(en)
|
2001-04-30 |
2007-08-14 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
HUP0303976A3
(en)
|
2001-05-08 |
2006-11-28 |
Merck Patent Gmbh |
Combination therapy using anti-egfr antibodies and hormone antagonists
|
|
DK1392359T4
(da)
|
2001-05-11 |
2013-06-10 |
Ludwig Inst For Cancer Res Ltd |
Specifikke bindingsproteiner og deres anvendelser.
|
|
US20100056762A1
(en)
*
|
2001-05-11 |
2010-03-04 |
Old Lloyd J |
Specific binding proteins and uses thereof
|
|
US20110313230A1
(en)
|
2001-05-11 |
2011-12-22 |
Terrance Grant Johns |
Specific binding proteins and uses thereof
|
|
CA2448319C
(en)
|
2001-05-31 |
2010-07-27 |
Medarex, Inc. |
Cytotoxins, prodrugs, linkers and stabilizers useful therefor
|
|
US6441163B1
(en)
|
2001-05-31 |
2002-08-27 |
Immunogen, Inc. |
Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
|
|
US7595378B2
(en)
|
2001-06-13 |
2009-09-29 |
Genmab A/S |
Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
|
|
KR20090125840A
(ko)
|
2001-06-13 |
2009-12-07 |
젠맵 에이/에스 |
표피 성장 인자 수용체 (ｅｇｆｒ)에 대한 인간 모노클로날 항체
|
|
US20050107595A1
(en)
|
2001-06-20 |
2005-05-19 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
US7803915B2
(en)
|
2001-06-20 |
2010-09-28 |
Genentech, Inc. |
Antibody compositions for the diagnosis and treatment of tumor
|
|
WO2003014159A1
(en)
|
2001-08-03 |
2003-02-20 |
Commonwealth Scientific And Industrial Research Organisation |
Methods of screening based on the egf receptor crystal structure
|
|
DE10138876B4
(de)
|
2001-08-08 |
2008-11-06 |
Forschungszentrum Jülich GmbH |
Genetisch modifizierte zyklisch-Nukleotid-gesteuerte lonenkanäle und deren Verwendung
|
|
US20030109682A1
(en)
|
2001-09-07 |
2003-06-12 |
Daniel Santi |
Maytansines and maytansine conjugates
|
|
JP2005502703A
(ja)
|
2001-09-07 |
2005-01-27 |
ザ スクリプス リサーチ インスティテュート |
Ｃｃ−１０６５およびデュオカルマイシンのｃｂｉ類似体
|
|
US7091186B2
(en)
|
2001-09-24 |
2006-08-15 |
Seattle Genetics, Inc. |
p-Amidobenzylethers in drug delivery agents
|
|
WO2003045312A2
(en)
|
2001-11-21 |
2003-06-05 |
University Of Washington |
Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin
|
|
US6716821B2
(en)
|
2001-12-21 |
2004-04-06 |
Immunogen Inc. |
Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
|
|
JP2005532258A
(ja)
|
2002-01-03 |
2005-10-27 |
スミスクライン・ビーチャム・コーポレイション |
免疫コンジュゲートの調製方法
|
|
US6790954B2
(en)
|
2002-01-29 |
2004-09-14 |
Immunogen, Inc. |
Mutant Actinosynnema pretiosum strain with increased maytansinoid production
|
|
CN101914158A
(zh)
*
|
2002-02-14 |
2010-12-15 |
免疫医疗公司 |
抗cd 20抗体及其融合蛋白和使用方法
|
|
WO2003072727A2
(en)
|
2002-02-25 |
2003-09-04 |
Georgetown University |
EGFRvIII SPECIFIC MONOCLONAL ANTIBODY AND EGFRvIII RIBOZYMES AND USE TO DETECT, TREAT OR PREVENT EGFRvIII ASSOCIATED CANCER
|
|
JP2005520539A
(ja)
|
2002-03-19 |
2005-07-14 |
ザ・ペン・ステート・リサーチ・ファンデーション |
Ｅｇｆｒリガンドおよび使用方法
|
|
US6534660B1
(en)
|
2002-04-05 |
2003-03-18 |
Immunogen, Inc. |
CC-1065 analog synthesis
|
|
US6756397B2
(en)
|
2002-04-05 |
2004-06-29 |
Immunogen, Inc. |
Prodrugs of CC-1065 analogs
|
|
US20050152913A1
(en)
|
2002-05-13 |
2005-07-14 |
Eldridge Ann M. |
Process for preapring maytansinol
|
|
US6596757B1
(en)
|
2002-05-14 |
2003-07-22 |
Immunogen Inc. |
Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use
|
|
US20040033543A1
(en)
|
2002-05-20 |
2004-02-19 |
Gisela Schwab |
Treatment of renal carcinoma using antibodies against the EGFr
|
|
AU2003241898A1
(en)
|
2002-06-03 |
2003-12-19 |
Mitsubishi Pharma Corporation |
PREVENTIVES AND/OR REMEDIES FOR SUBJECTS WITH THE EXPRESSION OR ACTIVATION OF Her2 AND/OR EGFR
|
|
CA2492092A1
(en)
|
2002-06-28 |
2004-01-08 |
Greg Winter |
Immunoglobin single variant antigen-binding domains and dual-specific constructs
|
|
US7696320B2
(en)
|
2004-08-24 |
2010-04-13 |
Domantis Limited |
Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor
|
|
ES2544527T3
(es)
|
2002-07-31 |
2015-09-01 |
Seattle Genetics, Inc. |
Conjugados de fármacos y su uso para tratar el cáncer, una enfermedad autoinmune o una enfermedad infecciosa
|
|
US7390898B2
(en)
|
2002-08-02 |
2008-06-24 |
Immunogen Inc. |
Cytotoxic agents containing novel potent taxanes and their therapeutic use
|
|
BR0313197A
(pt)
|
2002-08-02 |
2005-08-09 |
Immunogen Inc |
Agentes citotóxicos contendo potentes taxanos e seu uso terapêutico
|
|
DK1534335T4
(en)
|
2002-08-14 |
2015-10-05 |
Macrogenics Inc |
FCGAMMARIIB-SPECIFIC ANTIBODIES AND PROCEDURES FOR USE THEREOF
|
|
DE60336149D1
(de)
|
2002-08-16 |
2011-04-07 |
Immunogen Inc |
Vernetzer mit hoher reaktivität und löslichkeit und ihre verwendung bei der herstellung von konjugaten für die gezielte abgabe von kleinmolekularen arzneimitteln
|
|
CA2495389A1
(en)
|
2002-08-19 |
2004-02-26 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
RU2349340C2
(ru)
|
2002-10-10 |
2009-03-20 |
Мерк Патент Гмбх |
Биспецифические антитела к erb-b и их применение для лечения опухолей
|
|
EP1560599A1
(en)
|
2002-11-14 |
2005-08-10 |
Syntarga B.V. |
Prodrugs built as multiple self-elimination-release spacers
|
|
US20040147428A1
(en)
|
2002-11-15 |
2004-07-29 |
Pluenneke John D. |
Methods of treatment using an inhibitor of epidermal growth factor receptor
|
|
US20040202666A1
(en)
|
2003-01-24 |
2004-10-14 |
Immunomedics, Inc. |
Anti-cancer anthracycline drug-antibody conjugates
|
|
CA2450289A1
(en)
|
2003-03-20 |
2005-05-19 |
Imclone Systems Incorporated |
Method of producing an antibody to epidermal growth factor receptor
|
|
EP1622941A2
(en)
|
2003-03-20 |
2006-02-08 |
ImClone Systems Incorporated |
Method of producing an antibody to epidermal growth factor receptor
|
|
US7432088B2
(en)
|
2003-05-08 |
2008-10-07 |
Immunogen Inc. |
Methods for the production of ansamitocins
|
|
US20050026987A1
(en)
|
2003-05-13 |
2005-02-03 |
The Scripps Research Institute |
CBI analogues of the duocarmycins and CC-1065
|
|
US8088387B2
(en)
|
2003-10-10 |
2012-01-03 |
Immunogen Inc. |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
|
|
NZ543498A
(en)
|
2003-05-14 |
2007-06-29 |
Immunogen Inc |
A conjugate comprising an antibody chemically coupled to a maytansinoid
|
|
US7276497B2
(en)
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
|
US7736644B2
(en)
|
2003-06-27 |
2010-06-15 |
Amgen Fremont Inc. |
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
|
|
US8101720B2
(en)
|
2004-10-21 |
2012-01-24 |
Xencor, Inc. |
Immunoglobulin insertions, deletions and substitutions
|
|
CN1898267B
(zh)
*
|
2003-11-01 |
2012-05-23 |
默克专利股份有限公司 |
修饰的抗cd52抗体
|
|
CN103394083B
(zh)
|
2003-11-06 |
2017-07-18 |
西雅图基因公司 |
能够与配体偶联的单甲基缬氨酸化合物
|
|
US20050142133A1
(en)
|
2003-12-03 |
2005-06-30 |
Xencor, Inc. |
Optimized proteins that target the epidermal growth factor receptor
|
|
WO2005063816A2
(en)
|
2003-12-19 |
2005-07-14 |
Genentech, Inc. |
Monovalent antibody fragments useful as therapeutics
|
|
US20050214310A1
(en)
|
2004-01-23 |
2005-09-29 |
Seattle Genetics, Inc. |
Melphalan prodrugs
|
|
US7767792B2
(en)
*
|
2004-02-20 |
2010-08-03 |
Ludwig Institute For Cancer Research Ltd. |
Antibodies to EGF receptor epitope peptides
|
|
JP5064037B2
(ja)
|
2004-02-23 |
2012-10-31 |
ジェネンテック， インコーポレイテッド |
複素環式自壊的リンカーおよび結合体
|
|
CA2558399C
(en)
|
2004-03-02 |
2015-05-19 |
Seattle Genetics, Inc. |
Partially loaded antibodies and methods of their conjugation
|
|
TW200533339A
(en)
|
2004-03-16 |
2005-10-16 |
Bristol Myers Squibb Co |
Therapeutic synergy of anti-cancer compounds
|
|
MXPA06010715A
(es)
|
2004-03-19 |
2007-05-23 |
Imclone Systems Inc |
Anticuerpo del receptor del factor de crecimiento humano anti-epidermico.
|
|
WO2005092925A2
(en)
|
2004-03-24 |
2005-10-06 |
Xencor, Inc. |
Immunoglobulin variants outside the fc region
|
|
CN107988363A
(zh)
|
2004-03-31 |
2018-05-04 |
综合医院公司 |
测定癌症对表皮生长因子受体靶向性治疗反应性的方法
|
|
WO2005099754A2
(en)
|
2004-04-14 |
2005-10-27 |
The Ohio State University Research Foundation |
Maytansinoid analogs as antitumor agents
|
|
RU2402548C2
(ru)
|
2004-05-19 |
2010-10-27 |
Медарекс, Инк. |
Химические линкеры и их конъюгаты
|
|
AU2005244980B2
(en)
|
2004-05-19 |
2011-09-15 |
E. R. Squibb & Sons, L.L.C. |
Chemical linkers and conjugates thereof
|
|
CA2567520A1
(en)
|
2004-06-01 |
2005-12-15 |
Genentech, Inc. |
Maytansinoid-antibody conjugates
|
|
JP2008504809A
(ja)
|
2004-06-04 |
2008-02-21 |
ジェネンテック・インコーポレーテッド |
Ｅｇｆｒ突然変異
|
|
BRPI0513666A
(pt)
*
|
2004-08-05 |
2008-05-13 |
Genentech Inc |
anticorpos, anticorpos anti c-met humanizados, método de inibição de proliferação celular de c-met ativado, método de modulação de uma doença associada com descontrole de sinalização de hgf/c-met, método para o tratamento de um sujeito com cáncer, método para o tratamento de um distúrbio proliferativo, ácido nucléico, célula hospedeira e composição
|
|
US20060029574A1
(en)
|
2004-08-06 |
2006-02-09 |
Board Of Regents, The University Of Texas System |
Biomarkers for diagnosis, prognosis, monitoring, and treatment decisions for drug resistance and sensitivity
|
|
CN104447992A
(zh)
|
2004-09-23 |
2015-03-25 |
健泰科生物技术公司 |
半胱氨酸改造的抗体和偶联物
|
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
|
CA2586909A1
(en)
|
2004-11-12 |
2006-12-14 |
Seattle Genetics, Inc. |
Auristatins having an aminobenzoic acid unit at the n terminus
|
|
CA2587589A1
(en)
|
2004-11-29 |
2006-06-22 |
Seattle Genetics, Inc. |
Engineered antibodies and immunoconjugates
|
|
US20070134243A1
(en)
|
2004-12-01 |
2007-06-14 |
Gazzard Lewis J |
Antibody drug conjugates and methods
|
|
EP1688415A1
(en)
|
2004-12-07 |
2006-08-09 |
Aventis Pharma S.A. |
Cytotoxic agents comprising new C-2 modified taxanes
|
|
US20060121044A1
(en)
|
2004-12-07 |
2006-06-08 |
Genentech, Inc. |
Selecting patients for therapy with a her inhibitor
|
|
EP1669358A1
(en)
|
2004-12-07 |
2006-06-14 |
Aventis Pharma S.A. |
Cytotoxic agents comprising new taxanes
|
|
US7301019B2
(en)
|
2005-01-21 |
2007-11-27 |
Immunogen, Inc. |
Method for the preparation of maytansinoid esters
|
|
AU2006213662B2
(en)
|
2005-02-11 |
2010-08-05 |
Immunogen, Inc. |
Process for preparing stable drug conjugates
|
|
WO2006107854A2
(en)
|
2005-04-01 |
2006-10-12 |
Amgen Inc. |
Epidermal growth factor receptor gene copy number
|
|
US7714016B2
(en)
|
2005-04-08 |
2010-05-11 |
Medarex, Inc. |
Cytotoxic compounds and conjugates with cleavable substrates
|
|
EP2722051B1
(en)
|
2005-07-07 |
2018-11-07 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine side-chain modifications at the C-terminus
|
|
US8871720B2
(en)
|
2005-07-07 |
2014-10-28 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus
|
|
DK3248613T3
(da)
|
2005-07-18 |
2022-03-14 |
Seagen Inc |
Beta-glucuronid-lægemiddel-linkerkonjugater
|
|
EP1917030A4
(en)
|
2005-08-03 |
2011-03-09 |
Immunogen Inc |
IMMUNKONJUGATFORMULIERUNGEN
|
|
CA2617907A1
(en)
|
2005-08-05 |
2007-02-15 |
Syntarga B.V. |
Triazole-containing releasable linkers and conjugates comprising the same
|
|
AU2006280146B2
(en)
|
2005-08-09 |
2012-06-28 |
Immunogen, Inc. |
Method of acylating maytansinol with chiral amino acids
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
EP3539572A1
(en)
|
2005-08-24 |
2019-09-18 |
ImmunoGen, Inc. |
Process for preparing maytansinoid antibody conjugates
|
|
ES2416136T3
(es)
|
2005-09-26 |
2013-07-30 |
Medarex, Inc. |
Conjugados de anticuerpo-fármaco y su uso
|
|
AU2006305842B2
(en)
|
2005-10-26 |
2011-11-03 |
E. R. Squibb & Sons, L.L.C. |
Methods and compounds for preparing CC-1065 analogs
|
|
ATE540956T1
(de)
|
2005-11-08 |
2012-01-15 |
Immunogen Inc |
Verfahren zur herstellung von maytansinol
|
|
WO2007059404A2
(en)
|
2005-11-10 |
2007-05-24 |
Medarex, Inc. |
Duocarmycin derivatives as novel cytotoxic compounds and conjugates
|
|
SI1948180T1
(sl)
|
2005-11-11 |
2013-06-28 |
Boehringer Ingelheim International Gmbh |
Kombinacijsko zdravljenje raka, ki obsega EGFR/HER2 inhibitorje
|
|
CA2629095A1
(en)
|
2005-11-12 |
2007-05-24 |
Eli Lily And Company |
Anti-egfr antibodies
|
|
AU2006332212B8
(en)
|
2006-01-04 |
2013-05-30 |
Institut National De La Sante Et De La Recherche Medicale |
Combination therapy using anti-EGFR and anti-HER2 antibodies
|
|
AU2007210377B2
(en)
|
2006-02-02 |
2012-08-09 |
Georg-August-Universitat Gottingen Stiftung Offentlichen Rechts (Ohne Bereich Humanmedizin) |
Water-soluble CC-1065 analogs and their conjugates
|
|
US7750116B1
(en)
|
2006-02-18 |
2010-07-06 |
Seattle Genetics, Inc. |
Antibody drug conjugate metabolites
|
|
WO2007103288A2
(en)
|
2006-03-02 |
2007-09-13 |
Seattle Genetics, Inc. |
Engineered antibody drug conjugates
|
|
EP1832577A1
(en)
|
2006-03-07 |
2007-09-12 |
Sanofi-Aventis |
Improved prodrugs of CC-1065 analogs
|
|
US7651687B2
(en)
|
2006-03-13 |
2010-01-26 |
Osi Pharmaceuticals, Inc. |
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors
|
|
WO2008033495A2
(en)
*
|
2006-09-15 |
2008-03-20 |
Life Science Pharmaceuticals |
Method for detecting and treating skin disorders
|
|
AU2007317333A1
(en)
|
2006-11-02 |
2008-05-15 |
Seattle Genetics, Inc. |
Methods of treating neoplastic, autoimmune and inflammatory diseases
|
|
US7790164B2
(en)
|
2006-11-14 |
2010-09-07 |
Van Andel Research Institute |
Fragments of antibodies to epidermal growth factor receptor and methods of their use
|
|
WO2008063639A2
(en)
*
|
2006-11-21 |
2008-05-29 |
Massachusetts Eye And Ear Infirmary |
Compositions and methods for preserving cells of the eye
|
|
EP2091975A4
(en)
|
2006-11-21 |
2013-05-22 |
Univ California |
ANTIBODIES TO THE EGFR FAMILY, BICE-SPECIFIC ANTIBODIES TO THE EGFR FAMILY AND METHOD FOR THEIR USE
|
|
MX2009007987A
(es)
|
2007-01-25 |
2010-03-01 |
Dana Farber Cancer Inst Inc |
Uso de anticuerpos anti-egfr en el tratamiento de enfermedad mediada por egfr mutante.
|
|
WO2008115404A1
(en)
|
2007-03-15 |
2008-09-25 |
Ludwing Institute For Cancer Research |
Treatment method using egfr antibodies and src inhibitors and related formulations
|
|
WO2008152537A2
(en)
|
2007-06-14 |
2008-12-18 |
Zenotech Laboratories Limited |
Humanized monoclonal antibodies against human epidermal growth factor receptor, use and method thereof
|
|
WO2008154927A1
(en)
|
2007-06-21 |
2008-12-24 |
Genmab A/S |
Novel methods for treating egfr-associated tumors
|
|
EP2173739B1
(en)
|
2007-08-01 |
2013-07-31 |
Syntarga B.V. |
Substituted cc-1065 analogs and their conjugates
|
|
ES2609915T3
(es)
*
|
2007-08-14 |
2017-04-25 |
Ludwig Institute For Cancer Research Ltd. |
Anticuerpo monoclonal 175 direccionado al receptor de EGF y derivados y usos del mismo
|
|
US20090269343A1
(en)
|
2008-04-11 |
2009-10-29 |
Duke University |
Dual Specific Immunotoxin for Brain Tumor Therapy
|
|
CN104524592B
(zh)
|
2008-04-30 |
2018-06-05 |
伊缪诺金公司 |
交联剂和它们的用途
|
|
NZ589436A
(en)
|
2008-06-03 |
2012-12-21 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
NZ620649A
(en)
|
2009-02-05 |
2015-09-25 |
Immunogen Inc |
Novel benzodiazepine derivatives
|
|
JP2012525441A
(ja)
|
2009-05-01 |
2012-10-22 |
アボット・ラボラトリーズ |
二重可変ドメイン免疫グロブリンおよびこの使用
|
|
WO2011035465A1
(zh)
|
2009-09-22 |
2011-03-31 |
上海市肿瘤研究所 |
特异性结合蛋白及其使用
|
|
US20110076232A1
(en)
|
2009-09-29 |
2011-03-31 |
Ludwig Institute For Cancer Research |
Specific binding proteins and uses thereof
|
|
US9209965B2
(en)
|
2014-01-14 |
2015-12-08 |
Microsemi Semiconductor Ulc |
Network interface with clock recovery module on line card
|
